ALS-Like Disorder in Three HIV-Positive Patients: Case Series.

Case Rep Neurol

Department of Neurology, George Washington University Medical Faculty Associates, Washington, District of Columbia, USA.

Published: January 2021

There appears to be a relationship between retroviruses such as HIV and the development of an ALS-like syndrome. Few cases have been reported; however, there exists evidence of a higher frequency of motor neuron disease in HIV-infected patients, as well as potential slowing and reversibility of disease course with combination antiretroviral therapy. We conducted a retrospective chart review of patients presenting to the George Washington University ALS Clinic from September 2006 to June 2018 to identify patients with HIV receiving HAART who were subsequently diagnosed with ALS or an ALS-like disorder. Our goals were to describe our patients' disease course and compare them to general characteristics of ALS. We report three cases of HIV-positive individuals, all male, who were subsequently diagnosed with ALS. Each presented with symptoms of limb onset ALS with involvement of upper and lower motor neurons and whose disease originated at the cervical level. All three had been diagnosed with HIV prior to presentation and were presumably compliant with antiretroviral therapy throughout. Our patients demonstrated effective control of their HIV infection. Each experienced relatively slow progression of motor impairment compared to general ALS characteristics. Our study offers a distinct profile of HIV-positive patients compliant with HAART subsequently diagnosed with an ALS-like disorder. Further study should aim to uncover pathophysiological similarities between motor neuron disease both in the presence and absence of retroviral infection and to develop effective medical therapy for each.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923715PMC
http://dx.doi.org/10.1159/000511203DOI Listing

Publication Analysis

Top Keywords

als-like disorder
12
subsequently diagnosed
12
hiv-positive patients
8
motor neuron
8
neuron disease
8
disease course
8
antiretroviral therapy
8
haart subsequently
8
diagnosed als
8
patients
6

Similar Publications

Two cardinal features of ALS, reduced STMN2 and pathogenic TDP-43, synergize to accelerate motor decline in mice.

Exp Neurol

February 2025

Department of Developmental Biology, Washington University School of Medicine, St. Louis 63110, United States; Needleman Center for Neurometabolism and Axonal Therapeutics, St. Louis 63110, United States. Electronic address:

Pathological TDP-43 loss from the nucleus and cytoplasmic aggregation occurs in almost all cases of ALS and half of frontotemporal dementia patients. Stathmin2 (Stmn2) is a key target of TDP-43 regulation and aberrantly spliced Stmn2 mRNA is found in patients with ALS, frontotemporal dementia, and Alzheimer's Disease. STMN2 participates in the axon injury response and its depletion in vivo partially replicates ALS-like symptoms including progressive motor deficits and distal NMJ denervation.

View Article and Find Full Text PDF

Severe dynein dysfunction in cholinergic neurons exacerbates ALS-like phenotypes in a new mouse model.

Biochim Biophys Acta Mol Basis Dis

January 2025

Department of Neuroscience, School of Life Sciences, University of Sussex, Brighton, United Kingdom. Electronic address:

Cytoplasmic dynein 1, a motor protein essential for retrograde axonal transport, is increasingly implicated in the pathogenesis of neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS). In this study, we developed a novel mouse model that combines the Legs at odd angles (Loa, F580Y) point mutation in the dynein heavy chain with a cholinergic neuron-specific knockout of the dynein heavy chain. This model, for the first time, allows us to investigate the impact of Loa allele exclusivity in these neurons into adulthood.

View Article and Find Full Text PDF

Preservation of masseter muscle until the end stage in the SOD1G93A mouse model for ALS.

Sci Rep

October 2024

Department of Oral and Maxillofacial Surgery, Graduate School of Dentistry, Osaka University, 1-8 Yamadaoka, Suita, Osaka, 565-0871, Japan.

Amyotrophic lateral sclerosis (ALS) progressively impairs motor neurons, leading to muscle weakness and loss of voluntary muscle control. This study compared the effects of SOD1 mutation on masticatory and limb muscles from disease onset to death in ALS model mice. Notably, limb muscles begin to atrophy soon after ALS-like phenotype appear, whereas masticatory muscles maintain their volume and function in later stages.

View Article and Find Full Text PDF

Autoimmune astrocytopathy double negative for AQP4-IgG and GFAP-IgG: Retrospective research of clinical practice, biomarkers, and pathology.

CNS Neurosci Ther

September 2024

Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province, Department of Neurology, Institute of Neuroscience, Ministry of Education of China, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.

Article Synopsis
  • This study aimed to find astrocyte antibodies in patients, specifically looking for those not involving aquaporin-4 or GFAP antibodies, and assess related biomarkers and conditions.
  • Among the 116 patients tested, 35 were positive for astrocyte antibodies, with various neurological disorders noted, particularly encephalitis and myelitis, and higher levels of GFAP and NFL in those with unknown antibodies compared to controls.
  • The research suggests the presence of unidentified astrocyte antibodies and indicates that different neurological symptoms may lead to varied outcomes after immunotherapy, with some patients showing improvement.
View Article and Find Full Text PDF

CHCHD10 knock-in zebrafish display a mild ALS-like phenotype.

Exp Neurol

December 2024

Department of Neurology and Neurosurgery, Montreal Neurological Institute, Faculty of Medicine, McGill University, Canada. Electronic address:

Mutations in the nuclear-encoded mitochondrial gene CHCHD10 have been observed in patients with a spectrum of diseases that include amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). To investigate the pathogenic nature of disease-associated variants of CHCHD10 we generated a zebrafish knock-in (KI) model expressing the orthologous ALS-associated CHCHD10 variant (zebrafish: Chchd10). Larval chchd10 fish displayed reduced Chchd10 protein expression levels, motor impairment, reduced survival and abnormal neuromuscular junctions (NMJ).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!